Lysosomal Network Defects in Early-Onset Parkinson’s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199454 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alba Pascual und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, S…. Hauptthemen laut MEDLINE: Parkinson Disease, Lysosomes, Glucosylceramidase, alpha-Galactosidase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Investigación Sanitaria, Instituto Salud Carlos III, AGAUR/Generalitat de Catalunya and European Regional Development Fund (FEDER).
Abstract (Originalsprache)
Despite significant advances in understanding the genetics of Parkinson’s disease (PD) and Parkinsonism, the diagnostic yield remains low. Pathogenic variants of GBA1, which encodes the lysosomal enzyme β-glucocerebrosidase and causes recessive Gaucher dis-ease, are recognized as the most important genetic risk factor for PD in heterozygous carriers. This study focuses on the functional genomics of rare genetic variations in other lysosomal hydrolytic enzymes genes in patient-derived fibroblasts. We examined 49 early-onset PD patients using whole exome sequencing and in silico panel analysis based on a curated PD gene list. Two patients were found to carry the p.Asp313Tyr variant in the X-linked GLA gene (encoding GALA, typically associated with Fabry disease), and one patient carried the p.Arg419Gln variant in GLB1 (encoding β-Gal, linked to the recessive GM1 gangliosidosis and mucopolysaccharidosis type IVB). The in silico study of both variants supports a potentially damaging impact on the encoded protein function and structural destabilization. Additional candidate variants were found related to lysosomes, Golgi apparatus and neurodegeneration, suggesting a multifactorial contribution to the disease. However, none of these variants met diagnostic standards. Functional assays showed a significant decrease in GALA expression and partial retention of the enzyme in the trans-Golgi network in fibroblasts with GLA:p.Asp313Tyr, while altered Golgi morphology was observed in fibroblasts with GLB1:p.Arg419Gln. Moreover, all patients exhibited abnormalities in lysosomal morphology, altered lysosomal pH, and impaired autophagic flux. Our findings suggest that rare, heterozygous variants in lysosomal-related genes, even when individually insufficient for monogenic disease, can converge to impair lysosomal homeostasis and autophagic flux in EOPD. The underlying genetic and cellular heterogeneity among patients emphasizes the importance of combining genetic and functional approaches to better understand the mechanisms behind the EOPD, which could enhance both diagnosis and future treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurogenetics and Molecular Medicine, Center for Genomic Sciences in Medicine, Institut de Recerca Sant Joan de Déu, 08950 Barcelona, Spain.
- Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), 08035 Barcelona, Spain.
- Movement Disorders Unit, Neurology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
- Unit of Movement Disorders, Department of Neurology, Fundación Jimenez Díaz, 28040 Madrid, Spain.
- Rare Diseases & Pediatric Medicine Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Servicio Gallego de Salud-Universidad de Vigo (SERGAS-UVIGO), 36213 Vigo, Spain.
- Department of Biological Sciences, Faculty of Health Sciences, Universidad Técnica de Manabí, Portoviejo 130105, Ecuador.
ORCID-Profile: Thaleia Moulka, Roberta Repossi, Saida Ortolano, Marisel De Lucca, Marta Alves-Villar, Mònica Roldán, Francesc Palau, Jordi Pijuan, Janet Hoenicka
Förderung
- Fondo de Investigación Sanitaria, Instituto Salud Carlos III
- AGAUR/Generalitat de Catalunya and European Regional Development Fund (FEDER)
Zitieren
APA
Pascual, A., Moulka, T., de Fàbregues, O., Repossi, R., García-Ruiz, P. J., Ortolano, S., De Lucca, M., Vela-Desojo, L., Alves-Villar, M., Frías, M., Feliz-Feliz, C., Roldán, M., Olival, J., Fernàndez, G., Palau, F., Pijuan, J., & Hoenicka, J. (2025). Lysosomal Network Defects in Early-Onset Parkinson’s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199454
Vancouver
Pascual A, Moulka T, de Fàbregues O, Repossi R, García-Ruiz PJ, Ortolano S, et al. Lysosomal Network Defects in Early-Onset Parkinson’s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199454
BibTeX
@article{Pascual2025,
author = {Pascual, Alba and Moulka, Thaleia and de Fàbregues, Oriol and Repossi, Roberta and García-Ruiz, Pedro J and Ortolano, Saida and De Lucca, Marisel and Vela-Desojo, Lydia and Alves-Villar, Marta and Frías, Marcos and Feliz-Feliz, Cici and Roldán, Mònica and Olival, Jonathan and Fernàndez, Guerau and Palau, Francesc and Pijuan, Jordi and Hoenicka, Janet},
title = {Lysosomal Network Defects in Early-Onset Parkinson’s Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199454}
}
EUVIMED